logo logo
  • Home
  • About
  • News
  • Patient Stories
  • Videos
  • Make a Donation Online
  • Physicians
  • Forms
Oct 23, 2015 by Elyce Cardonick Category: Forms 0 comments

Loader Loading...
EAD Logo Taking too long?
Reload Reload document
| Open Open in new tab

Download [1.38 MB]

Share
Previous post Next post
Related Posts
  • Incidence of Neonatal Neutropenia and Leukopenia After In Utero Exposure to Chemotherapy for Maternal Cancer
    Aug 12, 2019  /  0 comments
  • The Use of Neupogen (Filgrastim) or Neulasta (Pegfilgrastim) during Pregnancy When Chemotherapy Is Indicated for Maternal Cancer Treatment
    Elyce Cardonick, Farhana Irfan, Natalie Torres ABSTRACT Intr...
    Oct 20, 2015  /  0 comments
  • Consent Form – Maternal Cancer Diagnosis
    Oct 23, 2015  /  0 comments

Leave a Comment! Cancel reply

Your email address will not be published. Required fields are marked *

Follow Us

Contact Information:

877.635.4499 or 856.757.7876

Recent Posts

  • Humans of CMSRU Story Dr. Elyce Cardonick, MD
  • Kathie’s Story: Is Chemotherapy Safe During Pregnancy?
  • Why this physician created the Cancer and Pregnancy Registry
  • Consent Form – Maternal Cancer Diagnosis – Spanish
  • Expert Guidance for Pregnant Women with Cancer

Categories

  • Forms
  • Latest News
  • Videos

Our Mission

Researching pregnant women with cancer and their children. By pooling information into a central registry we can accumulate stronger data to help oncologists, obstetricians and patients make informed decisions about treating cancer in pregnancy.

The Cancer and Pregnancy Fund of the Cooper Foundation is a 501(c)(3) nonprofit organization.

Elyce H. Cardonick, MD, FACOG

Board Certification(s): Obstetrics and Gynecology, Maternal and Fetal Medicine
Office Location(s): Burlington, Camden, Pomona, Princeton, Sewell, Voorhees
Medical Group: Cooper University Physician

View Dr. Cardonick's complete profile >

SEARCH

Copyright © 2019. CancerAndPregnancy.com. All Riights Reserved. Website Design by Surdej Web Solutions.
  • Follow: